These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20510728)

  • 1. Learning from leprosy: insight into the human innate immune response.
    Montoya D; Modlin RL
    Adv Immunol; 2010; 105():1-24. PubMed ID: 20510728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The innate immune response in leprosy.
    Modlin RL
    Curr Opin Immunol; 2010 Feb; 22(1):48-54. PubMed ID: 20060279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recognition mechanism of pathogen-associated molecular patterns and role of innate immune lymphocytes in fungal infection].
    Kawakami K
    Rinsho Byori; 2009 Aug; 57(8):779-85. PubMed ID: 19764413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leprosy as a model of immunity.
    Degang Y; Nakamura K; Akama T; Ishido Y; Luo Y; Ishii N; Suzuki K
    Future Microbiol; 2014; 9(1):43-54. PubMed ID: 24328380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy.
    Krutzik SR; Ochoa MT; Sieling PA; Uematsu S; Ng YW; Legaspi A; Liu PT; Cole ST; Godowski PJ; Maeda Y; Sarno EN; Norgard MV; Brennan PJ; Akira S; Rea TH; Modlin RL
    Nat Med; 2003 May; 9(5):525-32. PubMed ID: 12692544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome.
    Cardoso CC; Pereira AC; de Sales Marques C; Moraes MO
    Future Microbiol; 2011 May; 6(5):533-49. PubMed ID: 21585261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immune Responses in Leprosy.
    Pinheiro RO; Schmitz V; Silva BJA; Dias AA; de Souza BJ; de Mattos Barbosa MG; de Almeida Esquenazi D; Pessolani MCV; Sarno EN
    Front Immunol; 2018; 9():518. PubMed ID: 29643852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine patterns of immunologically mediated tissue damage.
    Yamamura M; Wang XH; Ohmen JD; Uyemura K; Rea TH; Bloom BR; Modlin RL
    J Immunol; 1992 Aug; 149(4):1470-5. PubMed ID: 1500726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathology of leprosy: the complexity of the mechanisms of host immune response to Mycobacterium leprae].
    Goulart IM; Penna GO; Cunha G
    Rev Soc Bras Med Trop; 2002; 35(4):365-75. PubMed ID: 12170333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I Interferons, Autophagy and Host Metabolism in Leprosy.
    Toledo Pinto TG; Batista-Silva LR; Medeiros RCA; Lara FA; Moraes MO
    Front Immunol; 2018; 9():806. PubMed ID: 29755459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7 in the cell-mediated immune response to a human pathogen.
    Sieling PA; Sakimura L; Uyemura K; Yamamura M; Oliveros J; Nickoloff BJ; Rea TH; Modlin RL
    J Immunol; 1995 Mar; 154(6):2775-83. PubMed ID: 7876548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of leprosy. New developments.
    Ottenhoff TH
    Trop Geogr Med; 1994; 46(2):72-80. PubMed ID: 8079394
    [No Abstract]   [Full Text] [Related]  

  • 20. M. leprae-HIV co-infection: pattern of immune response in vivo and in vitro.
    Nery JA; Sampaio EP; Galhardo MC; Perissé AR; Vieira LM; Salles AM; Sarno EN
    Indian J Lepr; 2000; 72(2):155-67. PubMed ID: 11008656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.